Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.21B |
| 2 |
Apple
AAPL
|
+$1.07B |
| 3 |
UnitedHealth
UNH
|
+$937M |
| 4 |
Broadcom
AVGO
|
+$737M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$608M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.25B |
| 3 |
Royal Bank of Canada
RY
|
+$1.15B |
| 4 |
TC Energy
TRP
|
+$1.11B |
| 5 |
Amazon
AMZN
|
+$969M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Financials | 8.69% |
| 3 | Consumer Discretionary | 7.16% |
| 4 | Healthcare | 6.71% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBNK
5626
VersaBank
VBNK
$631M
| $173K | ﹤0.01% |
+12,466
| New | +$191K |
|
5627
Actinium Pharmaceuticals
ATNM
$25.5M
| $170K | ﹤0.01% |
135,296
+43,903
| +48% | +$68.1K |
|
5628
Greenwich LifeSciences
GLSI
$199M
| $169K | ﹤0.01% |
+15,070
| New | +$202K |
|
5629
Rockwell Medical
RMTI
$28.5M
| $169K | ﹤0.01% |
8,268
+6,454
| +356% | +$188K |
|
5630
Fossil Group
FOSL
$348M
| $168K | ﹤0.01% |
100,526
+33,117
| +49% | +$48.4K |
|
|
VINC
5631
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $166K | ﹤0.01% |
31,570
-1
| -0% | -$7 |
|
5632
Invesco Municipal Trust
VKQ
$537M
| $165K | ﹤0.01% |
16,836
| – | – |
|
5633
PUT
Wendy's
WEN
$1.43B
| $163K | ﹤0.01% |
10,000
-190,000
| -95% | -$3.47M |
|
|
MRDN
5634
Meridian Holdings Inc
MRDN
$177M
| $162K | ﹤0.01% |
6,830
+4,387
| +180% | +$122K |
|
5635
Strawberry Fields REIT
STRW
$188M
| $159K | ﹤0.01% |
+15,078
| New | +$175K |
|
5636
Research Solutions
RSSS
$74.3M
| $158K | ﹤0.01% |
+37,967
| New | +$120K |
|
5637
WidePoint Corp
WYY
$103M
| $150K | ﹤0.01% |
+31,090
| New | +$134K |
|
5638
Cosan
CSAN
$3.19B
| $150K | ﹤0.01% |
27,488
-53,592
| -66% | -$403K |
|
5639
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
| $149K | ﹤0.01% |
+18,017
| New | +$157K |
|
|
SBDS
5640
DELISTED
Solo Brands Inc
SBDS
| $147K | ﹤0.01% |
3,216
+912
| +40% | +$45.2K |
|
|
RPTX
5641
DELISTED
Repare Therapeutics
RPTX
| $145K | ﹤0.01% |
+110,906
| New | +$330K |
|
5642
Century Therapeutics
IPSC
$357M
| $143K | ﹤0.01% |
141,583
+33,463
| +31% | +$45.6K |
|
5643
Inhibikase Therapeutics
IKT
$347M
| $143K | ﹤0.01% |
+43,952
| New | +$110K |
|
5644
Ramaco Resources Class B
METCB
$450M
| $142K | ﹤0.01% |
+15,163
| New | +$147K |
|
|
BOLD
5645
Boundless Bio
BOLD
$57.8M
| $141K | ﹤0.01% |
48,672
+37,316
| +329% | +$109K |
|
|
WBX
5646
Wallbox
WBX
$81.3M
| $141K | ﹤0.01% |
14,071
+9,280
| +194% | +$147K |
|
|
API
5647
Agora
API
$344M
| $141K | ﹤0.01% |
33,796
-3
| -0% | -$12 |
|
|
NINE
5648
DELISTED
Nine Energy Service
NINE
| $140K | ﹤0.01% |
+124,694
| New | +$147K |
|
|
ODV
5649
DELISTED
Osisko Development Corp
ODV
| $138K | ﹤0.01% |
84,488
+31,625
| +60% | +$59.1K |
|
5650
CareCloud
CCLD
$113M
| $137K | ﹤0.01% |
+37,538
| New | +$111K |
|
Similar funds
Goldman Sachs's Q4 2024 Portfolio in Review
As of Q4 2024, Goldman Sachs held 6,412 positions worth $634B, up 2.1% from $621B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Goldman Sachs's Q4 2024 filing shows 625 new, 2,947 increased, 1,944 reduced and 418 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 9,312,244 shares worth $236M. The largest sale was iShares Russell 2000 ETF, an estimated $1.41B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2024 buy was iShares Ethereum Trust ETF: 9,312,244 shares worth $236M.
- Goldman Sachs added most to Meta Platforms (Facebook) in Q4 2024, an estimated $1.21B increase.
- Goldman Sachs's biggest Q4 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $1.41B.
- Goldman Sachs fully exited Sterling Check Corp. Common Stock in Q4 2024, selling an estimated $833M.
- Goldman Sachs's ten largest holdings make up 21% of its $634B portfolio in Q4 2024.
- Goldman Sachs opened 625 new positions and closed 418 in Q4 2024.
- Goldman Sachs's portfolio value rose 2.1% quarter-over-quarter to $634B.
Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.